CIK 0001559053
- Accelerated filer
PROTHENA CORP PUBLIC LTD CO
Sign in to watch- Ticker
- PRTA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Ireland
- Entity type
- Operating
- Phone
- +353 12362500
- Business address
- 77 SIR JOHN ROGERSON'S QUAY, BLOCK C, GRAND CANAL DOCKLANDS, DUBLIN 2, Ireland, D02 VK60
- Former names
- Prothena Corp plc, Neotope Corp Ltd
- Open-market buys, last 90 days
- $9,848,721
- in 10 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$9,848,721. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-07-28 | Kinney Gene G. President and CEO | Option exercise | +84,000 | 152,793 | ||
| 2026-07-28 | Kinney Gene G. President and CEO | Returned to the company | −84,000 | $8.56 | $719K | 68,793 |
| 2026-07-28 | Kinney Gene G. President and CEO | Option exercise · Restricted Stock Units | −84,000 | 0 | ||
| 2026-03-03 | Kinney Gene G. President and CEO | Grant or award · Stock Option (Right to Buy) | +520,000 | 520,000 | ||
| 2025-07-28 | Kinney Gene G. President and CEO | Grant or award | +140,000 | 152,793 | ||
| 2025-03-05 | Kinney Gene G. President and CEO | Grant or award · Stock Option (Right to Buy) | +375,000 | 375,000 | ||
| 2024-02-27 | Kinney Gene G. President and CEO | Grant or award · Stock Option (Right to Buy) | +307,000 | 307,000 | ||
| 2023-05-17 | Kinney Gene G. President and CEO | Option exercise 10b5-1 | +45,000 | $29.81 | $1.3M | 57,793 |
| 2023-05-17 | Kinney Gene G. President and CEO | Sale 10b5-1 | −10,202 | $72.70 | $742K | 47,591 |
| 2023-05-17 | Kinney Gene G. President and CEO | Sale 10b5-1 | −19,864 | $73.60 | $1.5M | 27,727 |
| 2023-05-17 | Kinney Gene G. President and CEO | Sale 10b5-1 | −14,934 | $74.49 | $1.1M | 12,793 |
| 2023-05-17 | Kinney Gene G. President and CEO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −45,000 | 0 | ||
| 2023-03-02 | Kinney Gene G. President and CEO | Grant or award · Stock Option (Right to Buy) | +155,000 | 155,000 | ||
| 2022-09-28 | Kinney Gene G. President and CEO | Option exercise | +16,412 | $6.41 | $105K | 29,205 |
| 2022-09-28 | Kinney Gene G. President and CEO | Sale | −1,045 | $48.09 | $50K | 28,160 |
| 2022-09-28 | Kinney Gene G. President and CEO | Sale | −128 | $49.41 | $6K | 28,032 |
| 2022-09-28 | Kinney Gene G. President and CEO | Sale | −552 | $51.30 | $28K | 27,480 |
| 2022-09-28 | Kinney Gene G. President and CEO | Sale | −2,333 | $52.44 | $122K | 25,147 |
| 2022-09-28 | Kinney Gene G. President and CEO | Sale | −5,852 | $53.40 | $312K | 19,295 |
| 2022-09-28 | Kinney Gene G. President and CEO | Sale | −4,748 | $54.38 | $258K | 14,547 |
Page 1 of 3 · 51 trades